<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39323448</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2220-3249</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>World journal of virology</Title><ISOAbbreviation>World J Virol</ISOAbbreviation></Journal><ArticleTitle>Role of vitamin D in COVID-19 and other viral infections.</ArticleTitle><Pagination><StartPage>95349</StartPage><MedlinePgn>95349</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95349</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5501/wjv.v13.i3.95349</ELocationID><Abstract><AbstractText>Vitamin D is a steroid hormone that is naturally produced in the body or obtained through dietary sources, primarily under the influence of UVB radiation. This essential nutrient has a vital role in numerous physiological processes, encompassing immune function, cell growth, differentiation, insulin regulation, and cardiovascular well-being, along with its pivotal role in sustaining the delicate equilibrium of calcium and phosphate concentrations in the body. Moreover, vitamin D reinforces mucosal defense and bolsters the immune system through immunomodulation, making it a critical component of overall health. Numerous studies have unveiled the profound connection between vitamin D and the predisposition to respiratory tract infections, including well-known viruses such as influenza and the novel severe acute respiratory syndrome coronavirus 2. Vitamin D deficiency has been consistently linked to increased severity of coronavirus disease 2019 (COVID-19) and a heightened risk of mortality among afflicted individuals. Retrospective observational studies have further substantiated these findings, indicating that levels of vitamin D are linked with both the occurrence and severity of COVID-19 cases. Vitamin D has its influence on viral infections through a multitude of mechanisms, such as promoting the release of antimicrobial peptides and fine-tuning the responses of the immune system. Additionally, vitamin D is intertwined with the intricate network of the renin-angiotensin system, suggesting a potential impact on the development of complications related to COVID-19. While further clinical trials and extensive research are warranted, the existing body of evidence strongly hints at the possible use of vitamin D as a valuable tool in the prophylaxis and management of COVID-19 and other viral infectious diseases.</AbstractText><CopyrightInformation>©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Engin</LastName><ForeName>Muhammet Mesut Nezir</ForeName><Initials>MMN</Initials><AffiliationInfo><Affiliation>Private Outpatient Clinic of Child Follow-up Academy, Sakarya 54050, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Öner</ForeName><Initials>Ö</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, Sakarya Research and Training Hospital, Sakarya University, Faculty of Medicine, Sakarya 54100, Türkiye. onerozdemir@sakarya.edu.tr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Virol</MedlineTA><NlmUniqueID>101608353</NlmUniqueID><ISSNLinking>2220-3249</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Influenza virus</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Viral infections</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: All authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39323448</ArticleId><ArticleId IdType="pmc">PMC11401007</ArticleId><ArticleId IdType="doi">10.5501/wjv.v13.i3.95349</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18:153–165.</Citation><ArticleIdList><ArticleId IdType="pubmed">28516265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacker M, Holick MF. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111–148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3571641</ArticleId><ArticleId IdType="pubmed">23306192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bener A, Alsaied A, Al-Ali M, Al-Kubaisi A, Basha B, Abraham A, Guiter G, Mian M. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009;46:183–189.</Citation><ArticleIdList><ArticleId IdType="pubmed">18846317</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87:1738–1742.</Citation><ArticleIdList><ArticleId IdType="pubmed">18541563</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7:4240–4270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4488782</ArticleId><ArticleId IdType="pubmed">26035247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19:1067–1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">15985530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134:1129–1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2870528</ArticleId><ArticleId IdType="pubmed">16959053</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannell JJ, Vieth R, Willett W, Zasloff M, Hathcock JN, White JH, Tanumihardjo SA, Larson-Meyer DE, Bischoff-Ferrari HA, Lamberg-Allardt CJ, Lappe JM, Norman AW, Zittermann A, Whiting SJ, Grant WB, Hollis BW, Giovannucci E. Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol. 2008;117:864–870.</Citation><ArticleIdList><ArticleId IdType="pubmed">19102134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169:384–390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3447082</ArticleId><ArticleId IdType="pubmed">19237723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine (Baltimore) 2019;98:e17252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6756683</ArticleId><ArticleId IdType="pubmed">31567995</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231123</ArticleId><ArticleId IdType="pubmed">32252338</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpagnano GE, Di Lecce V, Quaranta VN, Zito A, Buonamico E, Capozza E, Palumbo A, Di Gioia G, Valerio VN, Resta O. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest. 2021;44:765–771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415009</ArticleId><ArticleId IdType="pubmed">32772324</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112–116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094998</ArticleId><ArticleId IdType="pubmed">16001071</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. Vitamin D and bone health. J Nutr. 1996;126:1159S–1164S.</Citation><ArticleIdList><ArticleId IdType="pubmed">8642450</ArticleId></ArticleIdList></Reference><Reference><Citation>Azmi H, Hassou N, Ennaji MM. Vitamin D immunomodulatory role in chronic and acute viral diseases. In: Ennaji MM, ed. Emerging and Reemerging Viral Pathogens. London, United Kingdom: Elsevier; 2020: 489-506.</Citation></Reference><Reference><Citation>Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009;65:106R–113R.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2925470</ArticleId><ArticleId IdType="pubmed">19190532</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res. 2011;55:96–108.</Citation><ArticleIdList><ArticleId IdType="pubmed">20824663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansdottir S, Monick MM. Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm. 2011;86:217–237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559187</ArticleId><ArticleId IdType="pubmed">21419273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21:319–329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968073</ArticleId><ArticleId IdType="pubmed">24529992</ArticleId></ArticleIdList></Reference><Reference><Citation>Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Rheum Dis Clin North Am. 2012;38:1–11, vii.</Citation><ArticleIdList><ArticleId IdType="pubmed">22525839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimalawansa SJ. Causes, benefits and consequences of vitamin D deficiency. J Community Med Health Res. 2019;2:1–4.</Citation></Reference><Reference><Citation>Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184:965–974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035054</ArticleId><ArticleId IdType="pubmed">20008294</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One. 2013;8:e65835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3686844</ArticleId><ArticleId IdType="pubmed">23840373</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham H, Rahman A, Majidi A, Waterhouse M, Neale RE. Acute Respiratory Tract Infection and 25-Hydroxyvitamin D Concentration: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2019;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747229</ArticleId><ArticleId IdType="pubmed">31438516</ArticleId></ArticleIdList></Reference><Reference><Citation>Panfili FM, Roversi M, D'Argenio P, Rossi P, Cappa M, Fintini D. Possible role of vitamin D in Covid-19 infection in pediatric population. J Endocrinol Invest. 2021;44:27–35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299247</ArticleId><ArticleId IdType="pubmed">32557271</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151055</ArticleId><ArticleId IdType="pubmed">12122115</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike JW, Christakos S. Biology and Mechanisms of Action of the Vitamin D Hormone. Endocrinol Metab Clin North Am. 2017;46:815–843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5762112</ArticleId><ArticleId IdType="pubmed">29080638</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharideinduced acute lung injury via regulation of the reninangiotensin system. Mol Med Rep. 2017;16:7432–7438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5865875</ArticleId><ArticleId IdType="pubmed">28944831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875–879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W, Sun Z, Liu F, Wu K, Zhong B, Mei Y, Zhang W, Chen Y, Li Y, Shi M, Lan K, Liu Y. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020;9:313–319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033720</ArticleId><ArticleId IdType="pubmed">32020836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med (Berl) 2006;84:814–820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079827</ArticleId><ArticleId IdType="pubmed">16988814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Rodríguez-Sabogal IA, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19) Infect. 2020;24:187.</Citation></Reference><Reference><Citation>Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020;80:373–377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102581</ArticleId><ArticleId IdType="pubmed">32109444</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanelli V, Ranieri VM. Mechanisms and clinical consequences of acute lung injury. Ann Am Thorac Soc. 2015;12 Suppl 1:S3–S8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25830831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario CM, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol. 2010;298:F1297–F1305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2886811</ArticleId><ArticleId IdType="pubmed">20375118</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166:646–650.</Citation><ArticleIdList><ArticleId IdType="pubmed">12204859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, Povoroznyuk V, Balatska N, Barbosa AP, Karonova T, Rudenka E, Misiorowski W, Zakharova I, Rudenka A, Łukaszkiewicz J, Marcinowska-Suchowierska E, Łaszcz N, Abramowicz P, Bhattoa HP, Wimalawansa SJ. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125–135.</Citation><ArticleIdList><ArticleId IdType="pubmed">28216084</ArticleId></ArticleIdList></Reference><Reference><Citation>Haq A, Wimalawansa SJ, Pludowski P, Anouti FA. Clinical practice guidelines for vitamin D in the United Arab Emirates. J Steroid Biochem Mol Biol. 2018;175:4–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">27693095</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, Wang X, Hu C, Ping R, Hu P, Li T, Cao F, Chang C, Hu Q, Jin Y, Xu G. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020;201:1372–1379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258652</ArticleId><ArticleId IdType="pubmed">32242738</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A, Carvas Junior N, Pericic TP, Zakarija-Grkovic I, Meirelles Guimarães SM, Luigi Bragazzi N, Bjorklund M, Sofi-Mahmudi A, Altujjar M, Tian M, Arcani DMC, O'Mathúna DP, Marcolino MS. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med. 2020;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7230636</ArticleId><ArticleId IdType="pubmed">32235486</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S Jr, Stelmach I, Kumar GT, Urashima M, Camargo CA Jr. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310969</ArticleId><ArticleId IdType="pubmed">28202713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010;5:e11088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885414</ArticleId><ArticleId IdType="pubmed">20559424</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010;202:809–814.</Citation><ArticleIdList><ArticleId IdType="pubmed">20632889</ArticleId></ArticleIdList></Reference><Reference><Citation>Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255–1260.</Citation><ArticleIdList><ArticleId IdType="pubmed">20219962</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry DJ, Hesketh K, Power C, Hyppönen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr. 2011;106:1433–1440.</Citation><ArticleIdList><ArticleId IdType="pubmed">21736791</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdoch DR, Slow S, Chambers ST, Jennings LC, Stewart AW, Priest PC, Florkowski CM, Livesey JH, Camargo CA, Scragg R. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 2012;308:1333–1339.</Citation><ArticleIdList><ArticleId IdType="pubmed">23032549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, Bergman P, Bischoff-Ferrari HA, Borzutzky A, Damsgaard CT, Dubnov-Raz G, Esposito S, Gilham C, Ginde AA, Golan-Tripto I, Goodall EC, Grant CC, Griffiths CJ, Hibbs AM, Janssens W, Khadilkar AV, Laaksi I, Lee MT, Loeb M, Maguire JL, Majak P, Mauger DT, Manaseki-Holland S, Murdoch DR, Nakashima A, Neale RE, Pham H, Rake C, Rees JR, Rosendahl J, Scragg R, Shah D, Shimizu Y, Simpson-Yap S, Trilok-Kumar G, Urashima M, Martineau AR. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9:276–292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo CA, Ingham AM, Spiegelman D, Avol ED, Berhane K, McConnell RS. Association of vitamin D with respiratory infections in children and adolescents. Pediatr Pulm. 2012;47:507–512.</Citation></Reference><Reference><Citation>Hollams EM, Teo SM, Kusel M, Holt BJ, Holt KE, Inouye M, De Klerk NH, Zhang G, Sly PD, Hart PH, Holt PG. Vitamin D over the first decade and susceptibility to childhood allergy and asthma. J Allergy Clin Immunol. 2017;139:472–481.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27726947</ArticleId></ArticleIdList></Reference><Reference><Citation>Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127:1294–1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">21315433</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Baggi E, Bianchini S, Marchisio P, Principi N. Role of vitamin D in children with respiratory tract infection. Int J Immunopathol Pharmacol. 2013;26:1–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23527704</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton KA, Marston GM, Rhee LM, Moser AA, McCune MM, Volberding CA. Vitamin D deficiency associated with increased risk of respiratory infections in HIV-positive adults receiving care in the United States. AIDS Patient Care and STDs. 2014;28:378–384.</Citation></Reference><Reference><Citation>Belderbos ME, Houben ML, Wilbrink B, Lentjes E, Bloemen EM, Kimpen JL, Rovers M, Bont L. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics. 2011;127:e1513–e1520.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555499</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally JD, Menon B, Chakraborty SF, Doherty M, Wong AI, Weiler OL, Volel RB, Dale ML, O’Hearn ML. Vitamin D deficiency in critically ill children: prevalence, risk factors, and outcome. Critical Care. 2009;13:R103.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Goaziou MF, Aubin-Auger S, Michel İK, Begaud P, Dervaux FA, Ameline A. Prevalence of vitamin D deficiency in children and adolescents and its impact on respiratory infections: a cross-sectional study. BMC Pediatrics. 2011;11:31.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Zhang X, Zhao Y, Liu J, Chen S. Low vitamin D status is associated with more frequent viral respiratory infections in children with chronic respiratory conditions. JPEM. 2020;33:1185–1190.</Citation></Reference><Reference><Citation>Grant WB, Cannell JJ, Garland CF, Giovannucci E, Goodman SM, Holicl MF. Vitamin D and influenza. Virol J. 2009;6:1–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloia JF, Mikhail A, Amir S, Ali A, Ellison A. Vitamin D status in African Americans living in the southeastern United States: the role of diet and supplement use. J Clin Endocr Metab. 2007;92:104–108.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, Quesada Gomez JM. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020;203:105751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, Silva CBR, Franco AS, Macedo MB, Dalmolin HHH, Baggio J, Balbi GGM, Reis BZ, Antonangelo L, Caparbo VF, Gualano B, Pereira RMR. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021;325:1053–1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890452</ArticleId><ArticleId IdType="pubmed">33595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N, Puri GD, Malhotra P. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study) Postgrad Med J. 2022;98:87–90.</Citation><ArticleIdList><ArticleId IdType="pubmed">33184146</ArticleId></ArticleIdList></Reference><Reference><Citation>Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, Hadadi A, Montazeri M, Nasiri M, Shirvani A, Holick MF. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One. 2020;15:e0239799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518605</ArticleId><ArticleId IdType="pubmed">32976513</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Hanotte B, Grandin de l'Eprevier C, Sabatier JM, Lafaie L, Célarier T. Vitamin D and survival in COVID-19 patients: A quasi-experimental study. J Steroid Biochem Mol Biol. 2020;204:105771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553119</ArticleId><ArticleId IdType="pubmed">33065275</ArticleId></ArticleIdList></Reference><Reference><Citation>Cangiano B, Foppiani F, Pestellini M, Brizzola L, Giustine C, Giustina L. Hypovitaminosis D and COVID-19: The potential role of vitamin D supplementation in elderly patients. Minerva Endocrinol. 2020;45:131–139.</Citation></Reference><Reference><Citation>Giannini S, Brandi ML, Camozzi P, Gragnano M, Biamonte A, Valerio ED, Cipriani M, Rovati G. Vitamin D supplementation and COVID-19 clinical outcomes: A systematic review and meta-analysis. J Endocrinol Invest. 2021;44:1875–1885.</Citation></Reference><Reference><Citation>Ling SF, Broadley MG, O’Reilly MW, Selvaraj WW, O’Donnell MM, Balchin LR. High-dose vitamin D supplementation reduces the risk of respiratory infections: a randomized trial. Clin Infect Dis. 2020;71:2707–2710.</Citation></Reference><Reference><Citation>Tan CW, Mathur A, Mong BY, Tan SC, Jarvinen MT Li X, Lim E, Shi L, Zhang DBH, Wan YS. Vitamin D supplementation in patients with COVID-19: a randomized controlled trial. Nutrients. 2020;12:3653.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.</Citation><ArticleIdList><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A, Allegrini P, Faliva MA, Peroni G, Nichetti M, Perna S. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evid Based Complement Alternat Med. 2018;2018:5813095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5949172</ArticleId><ArticleId IdType="pubmed">29853961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kast JI, McFarlane AJ, Głobińska A, Sokolowska M, Wawrzyniak P, Sanak M, Schwarze J, Akdis CA, Wanke K. Respiratory syncytial virus infection influences tight junction integrity. Clin Exp Immunol. 2017;190:351–359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5680068</ArticleId><ArticleId IdType="pubmed">28856667</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Leng K, Lu Y, Wen L, Qi Y, Gao W, Chen H, Bai L, An X, Sun B, Wang P, Dong J. Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010-2018. Epidemiol Infect. 2020;148:e29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026897</ArticleId><ArticleId IdType="pubmed">32054544</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi GA, Fanous H, Colin AA. Viral strategies predisposing to respiratory bacterial superinfections. Pediatr Pulmonol. 2020;55:1061–1073.</Citation><ArticleIdList><ArticleId IdType="pubmed">32084305</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc. 2010;69:286–289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3138329</ArticleId><ArticleId IdType="pubmed">20515520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol. 1985;134:3032–3035.</Citation><ArticleIdList><ArticleId IdType="pubmed">3156926</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7:3011–3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4425186</ArticleId><ArticleId IdType="pubmed">25912039</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183:5458–5467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2810518</ArticleId><ArticleId IdType="pubmed">19843932</ArticleId></ArticleIdList></Reference><Reference><Citation>Vásárhelyi B, Sátori A, Olajos F, Szabó A, Beko G. [Low vitamin D levels among patients at Semmelweis University: retrospective analysis during a one-year period] Orv Hetil. 2011;152:1272–1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">21803724</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology Working Group for NCIP Epidemic Response. Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–151.</Citation><ArticleIdList><ArticleId IdType="pubmed">32064853</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536–1538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC424123</ArticleId><ArticleId IdType="pubmed">2997282</ArticleId></ArticleIdList></Reference><Reference><Citation>Gröber U, Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol. 2012;4:158–166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427195</ArticleId><ArticleId IdType="pubmed">22928072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei GS, Zhang C, Cheng BH, Lee CH. Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. Antimicrob Agents Chemother. 2017;61</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610499</ArticleId><ArticleId IdType="pubmed">28760906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi S, Bereswill S, Heimesaat MM. Immunomodulatory and Antimicrobial Effects of Vitamin C. Eur J Microbiol Immunol (Bp) 2019;9:73–79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798581</ArticleId><ArticleId IdType="pubmed">31662885</ArticleId></ArticleIdList></Reference><Reference><Citation>Colunga Biancatelli RML, Berrill M, Marik PE. The antiviral properties of vitamin C. Expert Rev Anti Infect Ther. 2020;18:99–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">31852327</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatram S, Chilimuri S, Adrish M, Salako A, Patel M, Diaz-Fuentes G. Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care. 2011;15:R292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3388639</ArticleId><ArticleId IdType="pubmed">22152332</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90:387–392.</Citation><ArticleIdList><ArticleId IdType="pubmed">15225806</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003;88:327–331.</Citation><ArticleIdList><ArticleId IdType="pubmed">12520534</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. Vitamin D and the renin-angiotensin system: Feldman D, ed. Vitamin D. London, United Kingdom: Academic Press; 2018: 825-847.</Citation></Reference><Reference><Citation>Ishii K, Takeuchi H, Fukunaga K, Hirano Y, Suda K, Hagiwara T, Miyasho T, Yamada S, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Betsuyaku T, Ichihara A, Kitagawa Y. Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade. Exp Lung Res. 2015;41:199–207.</Citation><ArticleIdList><ArticleId IdType="pubmed">25844689</ArticleId></ArticleIdList></Reference><Reference><Citation>Laplana M, Royo JL, Fibla J. Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis. Gene. 2018;678:384–394.</Citation><ArticleIdList><ArticleId IdType="pubmed">30092343</ArticleId></ArticleIdList></Reference><Reference><Citation>Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019;29:e2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">30614127</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol. 2020;42:3–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32342926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Zhu X, Shi Y, Liu T, Chen Y, Bhan I, Zhao Q, Thadhani R, Li YC. VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol. 2013;27:2116–2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857197</ArticleId><ArticleId IdType="pubmed">24196349</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi YY, Liu TJ, Fu JH, Xu W, Wu LL, Hou AN, Xue XD. Vitamin D/VDR signaling attenuates lipopolysaccharideinduced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep. 2016;13:1186–1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4732862</ArticleId><ArticleId IdType="pubmed">26675943</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401–420.</Citation><ArticleIdList><ArticleId IdType="pubmed">10707958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181:7090–7099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596683</ArticleId><ArticleId IdType="pubmed">18981129</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB, Peiris AN. Antimicrobial implications of vitamin D. Dermatoendocrinol. 2011;3:220–229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256336</ArticleId><ArticleId IdType="pubmed">22259647</ArticleId></ArticleIdList></Reference><Reference><Citation>Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010;87:79–92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167086</ArticleId><ArticleId IdType="pubmed">19808939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–2912.</Citation><ArticleIdList><ArticleId IdType="pubmed">15322146</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses. 2019;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6357155</ArticleId><ArticleId IdType="pubmed">30646565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019;23:258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642581</ArticleId><ArticleId IdType="pubmed">31324202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope-Simpson RE. The role of season in the epidemiology of influenza. J Hyg (Lond) 1981;86:35–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2134066</ArticleId><ArticleId IdType="pubmed">7462597</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E. On the epidemiology of influenza. Virol J. 2008;5:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2279112</ArticleId><ArticleId IdType="pubmed">18298852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, Zhang K, Clarke N, Xie M, Reitz RE, Suffin SC, Holick MF. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PLoS One. 2015;10:e0118108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349787</ArticleId><ArticleId IdType="pubmed">25738588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007;3:1470–1476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034399</ArticleId><ArticleId IdType="pubmed">17953482</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci U S A. 2009;106:3243–3248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2651255</ArticleId><ArticleId IdType="pubmed">19204283</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol. 2010;8:e1000316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2826374</ArticleId><ArticleId IdType="pubmed">20186267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Du J, Huang L, Wang Y, Shi Y, Lin H. Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial. Pediatr Infect Dis J. 2018;37:749–754.</Citation><ArticleIdList><ArticleId IdType="pubmed">29315160</ArticleId></ArticleIdList></Reference><Reference><Citation>Urashima M, Mezawa H, Noya M, Camargo CA Jr. Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trial. Food Funct. 2014;5:2365–2370.</Citation><ArticleIdList><ArticleId IdType="pubmed">25088394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD, Greiffenstein P. Vitamin D insufficiency is prevalent in severe COVID-19. medRxiv. 2020</Citation></Reference><Reference><Citation>Zittermann A. The estimated benefits of vitamin D for infectious diseases. Int J Infect Dis. 2010;14:e728–e731.</Citation></Reference><Reference><Citation>Nieman DC. Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc. 1994;26:128–139.</Citation><ArticleIdList><ArticleId IdType="pubmed">8164529</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda A, Tamano J, Kan Y, Itoh H, Oku S, Sakamoto N. Zinc deficiency and its effect on the brain: an update. Biom Res. 2017;28:1815–1823.</Citation></Reference><Reference><Citation>Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabet Metab Syndr: Clin Res Rev. 2020;14:561–565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204679</ArticleId><ArticleId IdType="pubmed">32413819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020;32:1195–1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202265</ArticleId><ArticleId IdType="pubmed">32377965</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicio EJ.  Vitamin D level of mild and severe elderly cases of COVID-19: a preliminary report. 2020. Available from: https://ssrn.com/abstract=3593258 .</Citation></Reference><Reference><Citation>Darling AL, Ahmadi KR, Ward KA, Harvey NC, Couto Alves A, Dunn-Waters DK, Lanham-New SA, Cooper C, Blackbourn DJ. Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n:580) compared with negative controls (n:723) 2020 Preprint</Citation></Reference><Reference><Citation>Raharusun P, Priambada S, Budiarti C, Agung E, Budi C. Patterns of COVID-19 mortality and vitamin D: an Indonesian study. SSRN Electronic Journal</Citation></Reference><Reference><Citation>Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin Exp Res. 2020;32:2141–2158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465887</ArticleId><ArticleId IdType="pubmed">32876941</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>